- Home
- AXR vs LUCD Comparison
AXR vs LUCD Comparison
Compare AXR & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXR
- LUCD
- Stock Information
- Founded
- AXR 1961
- LUCD 2018
- Country
- AXR United States
- LUCD United States
- Employees
- AXR N/A
- LUCD N/A
- Industry
- AXR Homebuilding
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AXR Real Estate
- LUCD Health Care
- Exchange
- AXR Nasdaq
- LUCD Nasdaq
- Market Cap
- AXR 117.0M
- LUCD 105.0M
- IPO Year
- AXR N/A
- LUCD 2021
- Fundamental
- Price
- AXR $21.58
- LUCD $1.26
- Analyst Decision
- AXR
- LUCD Strong Buy
- Analyst Count
- AXR 0
- LUCD 4
- Target Price
- AXR N/A
- LUCD $3.94
- AVG Volume (30 Days)
- AXR 6.2K
- LUCD 766.0K
- Earning Date
- AXR 09-12-2025
- LUCD 08-13-2025
- Dividend Yield
- AXR N/A
- LUCD N/A
- EPS Growth
- AXR 89.60
- LUCD N/A
- EPS
- AXR 2.37
- LUCD N/A
- Revenue
- AXR $49,694,000.00
- LUCD $4,360,000.00
- Revenue This Year
- AXR $12.31
- LUCD $22.80
- Revenue Next Year
- AXR $8.40
- LUCD $221.19
- P/E Ratio
- AXR $9.06
- LUCD N/A
- Revenue Growth
- AXR N/A
- LUCD 14.74
- 52 Week Low
- AXR $17.60
- LUCD $0.73
- 52 Week High
- AXR $39.68
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- AXR 43.71
- LUCD 68.40
- Support Level
- AXR $21.45
- LUCD $0.98
- Resistance Level
- AXR $22.91
- LUCD $1.29
- Average True Range (ATR)
- AXR 0.53
- LUCD 0.07
- MACD
- AXR -0.03
- LUCD 0.03
- Stochastic Oscillator
- AXR 8.90
- LUCD 85.74
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.